3 completed, 1 withdrawn. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Withdrawn 1 |
Follow ioflupane: new trials by email Literature Review of ioflupane trials Research Report on ioflupane
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
Parkinson Disease (2) · Amyotrophic Lateral Sclerosis (1) · Dementia, Vascular (1) · Essential Tremor (1) · Lewy Body Disease (1) · Multiple System Atrophy (1) · Parkinsonian Disorders (1) · Supranuclear Palsy, Progressive (1)
GE Healthcare (2) · Assistance Publique - Hôpitaux de Paris (1) · Navidea Biopharmaceuticals (1)
China (1) · France (1) · Germany (1) · United States (1)
Cornelia Reininger, M.D. Ph.D. (1) · Lucette Lacomblez, MD (1) · Marc Pignot, PhD (1)